Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 11 | 19 | 11 | 13 | 14 |
| Gross Profit | 11 | 10 | 11 | 13 | 14 |
| Operating Expenses | 8,564 | 8,001 | 8,542 | 7,633 | 7,580 |
| Operating Income | -8,553 | -7,982 | -8,531 | -7,620 | -7,566 |
| Interest Expense | 616 | 542 | 511 | 505 | 503 |
| Other Income | 96 | 87 | 42 | 83 | 63 |
| Pre-tax Income | -9,073 | -8,437 | -9,000 | -8,042 | -8,006 |
| Income Tax | N/A | 1 | N/A | N/A | N/A |
| Net Income Continuous | -9,073 | -8,438 | -9,000 | -8,042 | -8,006 |
| Net Income | $-9,073 | $-8,438 | $-9,000 | $-8,042 | $-8,006 |
| EPS Basic Total Ops | -1,540.48 | -1,435.53 | -1,532.98 | -1,371.81 | -1,364.32 |
| EPS Basic Continuous Ops | -1,540.16 | -1,435.05 | -1,532.63 | -1,370.73 | -1,365.22 |
| EPS Diluted Total Ops | -1,540.48 | -1,435.53 | -1,532.98 | -1,371.81 | -1,364.32 |
| EPS Diluted Continuous Ops | -1,540.16 | -1,435.05 | -1,532.63 | -1,370.73 | -1,365.22 |
| EBITDA(a) | $-8,487 | $-7,937 | $-8,463 | $-7,556 | $-7,503 |